Gastroenterology
Volume 131, Issue 1 , Pages 283-311 , July 2006

American Gastroenterological Association Institute Technical Review on the Use of Gastrointestinal Medications in Pregnancy

  • Uma Mahadevan

      Affiliations

    • Division of Gastroenterology, Department of Medicine, University of California, San Francisco, San Francisco, California
    • Corresponding Author InformationAddress requests for reprints to: Chair, Clinical Practice and Economics Committee, AGA Institute National Office, c/o Membership Department, 4930 Del Ray Avenue, Bethesda, Maryland 20814. Fax: (301) 654-5920.
    • ,
  • Sunanda Kane

      Affiliations

    • Division of Gastroenterology, Department of Medicine, University of Chicago, Chicago, Illinois

References 

  1. Jefferies JA, Robboy SJ, O’Brien PC, Bergstralh EJ, Labarthe DR, Barnes AB, et al. Structural anomalies of the cervix and vagina in women enrolled in the Diethylstilbestrol Adenosis (DESAD) Project . Am J Obstet Gynecol . 1984;148:59–66
  2. Briggs GG , Freeman RK , Yaffe SJ . Drugs in pregnancy and lactation . 7th ed.. Philadelphia, PA: Lippincott, Williams & Wilkins; 2005;
  3. American Academy of Pediatrics Committee on Drugs . The transfer of drugs and other chemicals into human milk . Pediatrics . 2001;108:776–789
  4. U.S. Department of Education and Welfare PHS, National Institutes of Health. The Collaborative Study of the National Institute of Neurological Diseases: The Women and Their Pregnancies. DHEW Publication No. (NIH) 73-379, 1972.
  5. Schwethelm B , Margolis LH , Miller C , Smith S . Risk status and pregnancy outcome among Medicaid recipients . Am J Prev Med . 1989;5:157–163
  6. Fairlie FM , Marshall L , Walker JJ , Elbourne D . Intramuscular opioids for maternal pain relief in labour (a randomised controlled trial comparing pethidine with diamorphine) . Br J Obstet Gynaecol . 1999;106:1181–1187
  7. Tsui MH , Ngan Kee WD , Ng FF , Lau TK . A double blinded randomised placebo-controlled study of intramuscular pethidine for pain relief in the first stage of labour . BJOG . 2004;111:648–655
  8. Barrett JM , Boehm FH . Fetal heart rate responses to meperidine alone and in combination with propiomazine . South Med J . 1983;76:1480–1483
  9. Peiker G , Muller B , Ihn W , Noschel H . [Excretion of pethidine in mother’s milk . (author’s transl)] Zentralbl Gynakol . 1980;102:537–541
  10. Quinn PG , Kuhnert BR , Kaine CJ , Syracuse CD . Measurement of meperidine and normeperidine in human breast milk by selected ion monitoring . Biomed Environ Mass Spectrom . 1986;13:133–135
  11. Martin LV , Jurand A . The absence of teratogenic effects of some analgesics used in anaesthesia. Additional evidence from a mouse model . Anaesthesia . 1992;47:473–476
  12. Fernando R , Bonello E , Gill P , Urquhart J , Reynolds F , Morgan B . Neonatal welfare and placental transfer of fentanyl and bupivacaine during ambulatory combined spinal epidural analgesia for labour . Anaesthesia . 1997;52:517–524
  13. Morley-Forster PK , Reid DW , Vandeberghe H . A comparison of patient-controlled analgesia fentanyl and alfentanil for labour analgesia . Can J Anaesth . 2000;47:113–119
  14. Nelson KE , Rauch T , Terebuh V , D’Angelo R . A comparison of intrathecal fentanyl and sufentanil for labor analgesia . Anesthesiology . 2002;96:1070–1073
  15. Rayburn W , Rathke A , Leuschen MP , Chleborad J , Weidner W . Fentanyl citrate analgesia during labor . Am J Obstet Gynecol . 1989;161:202–206
  16. Carrie LE , O’Sullivan GM , Seegobin R . Epidural fentanyl in labour . Anaesthesia . 1981;36:965–969
  17. Lindemann R . Respiratory muscle rigidity in a preterm infant after use of fentanyl during Caesarean section . Eur J Pediatr . 1998;157:1012–1013
  18. Regan J , Chambers F , Gorman W , MacSullivan R . Neonatal abstinence syndrome due to prolonged administration of fentanyl in pregnancy . BJOG . 2000;107:570–572
  19. Celleno D , Capogna G , Tomassetti M , Costantino P , Di Feo G , Nisini R . Neurobehavioural effects of propofol on the neonate following elective caesarean section . Br J Anaesth . 1989;62:649–654
  20. Abboud TK , Zhu J , Richardson M , Peres Da Silva E , Donovan M . Intravenous propofol vs thiamylal-isoflurane for caesarean section, comparative maternal and neonatal effects . Acta Anaesthesiol Scand . 1995;39:205–209
  21. Cheng YJ , Wang YP , Fan SZ , Liu CC . Intravenous infusion of low dose propofol for conscious sedation in cesarean section before spinal anesthesia . Acta Anaesthesiol Sin . 1997;35:79–84
  22. Gregory MA , Gin T , Yau G , Leung RK , Chan K , Oh TE . Propofol infusion anaesthesia for caesarean section . Can J Anaesth . 1990;37:514–520
  23. Dailland P, Cockshott ID, Lirzin JD, Jacquinot P, Jorrot JC, Devery J, et al. Intravenous propofol during cesarean section: placental transfer, concentrations in breast milk, and neonatal effects. A preliminary study . Anesthesiology . 1989;71:827–834
  24. American Academy of Pediatrics Committee on Drugs . Naloxone use in newborns . Pediatrics . 1980;65:667–669
  25. Smotherman WP , Robinson SR . Prenatal experience with milk (fetal behavior and endogenous opioid systems) . Neurosci Biobehav Rev . 1992;16:351–364
  26. Safra MJ , Oakley GP . Association between cleft lip with or without cleft palate and prenatal exposure to diazepam . Lancet . 1975;2:478–480
  27. Czeizel A . Lack of evidence of teratogenicity of benzodiazepine drugs in Hungary . Reprod Toxicol . 1987;1:183–188
  28. Bracken MB , Holford TR . Exposure to prescribed drugs in pregnancy and association with congenital malformations . Obstet Gynecol . 1981;58:336–344
  29. Rothman KJ , Fyler DC , Goldblatt A , Kreidberg MB . Exogenous hormones and other drug exposures of children with congenital heart disease . Am J Epidemiol . 1979;109:433–439
  30. Ornoy A , Arnon J , Shechtman S , Moerman L , Lukashova I . Is benzodiazepine use during pregnancy really teratogenic? . Reprod Toxicol . 1998;12:511–515
  31. Dolovich LR , Addis A , Vaillancourt JM , Power JD , Koren G , Einarson TR . Benzodiazepine use in pregnancy and major malformations or oral cleft (meta-analysis of cohort and case-control studies) . BMJ . 1998;317:839–843
  32. Wesson DR , Camber S , Harkey M , Smith DE . Diazepam and desmethyldiazepam in breast milk . J Psychoactive Drugs . 1985;17:55–56
  33. Bland BA , Lawes EG , Duncan PW , Warnell I , Downing JW . Comparison of midazolam and thiopental for rapid sequence anesthetic induction for elective cesarean section . Anesth Analg . 1987;66:1165–1168
  34. Celleno D, Capogna G, Emanuelli M, Varrassi G, Muratori F, Costantino P, et al. Which induction drug for cesarean section? A comparison of thiopental sodium, propofol, and midazolam . J Clin Anesth . 1993;5:284–288
  35. Cappell MS , Colon VJ , Sidhom OA . A study at 10 medical centers of the safety and efficacy of 48 flexible sigmoidoscopies and 8 colonoscopies during pregnancy with follow-up of fetal outcome and with comparison to control groups . Dig Dis Sci . 1996;41:2353–2361
  36. Cappell MS , Colon VJ , Sidhom OA . A study of eight medical centers of the safety and clinical efficacy of esophagogastroduodenoscopy in 83 pregnant females with follow-up of fetal outcome with comparison control groups . Am J Gastroenterol . 1996;91:348–354
  37. Matheson I , Lunde PK , Bredesen JE . Midazolam and nitrazepam in the maternity ward (milk concentrations and clinical effects) . Br J Clin Pharmacol . 1990;30:787–793
  38. Stahl MM , Saldeen P , Vinge E . Reversal of fetal benzodiazepine intoxication using flumazenil . Br J Obstet Gynaecol . 1993;100:185–188
  39. Shin YK , Collea JV , Kim YD . The effect of glucagon on spontaneous contractility of isolated pregnant uterine muscle . Obstet Gynecol . 1996;88:867–871
  40. Rayburn W , Piehl E , Sanfield J , Compton A . Reversing severe hypoglycemia during pregnancy with glucagon therapy . Am J Perinatol . 1987;4:259–261
  41. Czeizel AE , Rockenbauer M , Sorensen HT , Olsen J . A population-based case-control teratologic study of ampicillin treatment during pregnancy . Am J Obstet Gynecol . 2001;185:140–147
  42. Matsuda S . Transfer of antibiotics into maternal milk . Biol Res Pregnancy Perinatol . 1984;5:57–60
  43. Czeizel AE , Rockenbauer M , Olsen J , Sorensen HT . A teratological study of aminoglycoside antibiotic treatment during pregnancy . Scand J Infect Dis . 2000;32:309–313
  44. Celiloglu M , Celiker S , Guven H , Tuncok Y , Demir N , Erten O . Gentamicin excretion and uptake from breast milk by nursing infants . Obstet Gynecol . 1994;84:263–265
  45. Nardulli G , Limongi F , Sue G , Zapata L , Bompart I . [Use of polyethylene glycol in the treatment of puerperal constipation] . G. E. N. . 1995;49:224–226
  46. Rimensberger P , Schubiger G , Willi U . Connatal rickets following repeated administration of phosphate enemas in pregnancy (a case report) . Eur J Pediatr . 1992;151:54–56
  47. Morrison JC, Boyd M, Friedman BI, Bucovaz ET, Whybrew WD, Koury DN, et al. The effects of Renografin-60 on the fetal thyroid . Obstet Gynecol . 1973;42:99–103
  48. Sorensen HT , Nielsen GL , Christensen K , Tage-Jensen U , Ekbom A , Baron J  The Euromap study group . Birth outcome following maternal use of metoclopramide . Br J Clin Pharmacol . 2000;49:264–268
  49. Berkovitch M, Mazzota P, Greenberg R, Elbirt D, Addis A, Schuler-Faccini L, et al. Metoclopramide for nausea and vomiting of pregnancy (a prospective multicenter international study) . Am J Perinatol . 2002;19:311–316
  50. Vella L , Francis D , Houlton P , Reynolds F . Comparison of the antiemetics metoclopramide and promethazine in labour . Br Med J (Clin Res Ed) . 1985;290:1173–1175
  51. Breslow S , Belafsky HA , Shangold JE , Hirsch LM , Stahl MB . Antiemetic effect of trimethobenzamide in pregnant patients . Clin Otorinolaringoiatr . 1961;8:2153–2155
  52. Miklovich L , van den Berg BJ . An evaluation of the teratogenicity of certain antinauseant drugs . Am J Obstet Gynecol . 1976;125:244–248
  53. Winters HS . Antiemetics in nausea and vomiting of pregnancy . Obstet Gynecol . 1961;18:753–756
  54. Sullivan CA , Johnson CA , Roach H , Martin RW , Stewart DK , Morrison JC . A pilot study of intravenous ondansetron for hyperemesis gravidarum . Am J Obstet Gynecol . 1996;174:1565–1568
  55. Einarson A , Maltepe C , Navioz Y , Kennedy D , Tan MP , Koren G . The safety of ondansetron for nausea and vomiting of pregnancy (a prospective comparative study) . BJOG . 2004;111:940–943
  56. Kytril [package insert] . Philadelphia, PA: SmithKline Beecham; 1997;
  57. Ching CK , Lam SK . Antacids. Indications and limitations . Drugs . 1994;47:305–317
  58. Witter FR , King TM , Blake DA . The effects of chronic gastrointestinal medication on the fetus and neonate . Obstet Gynecol . 1981;58:79S–84S
  59. McGuinness B , Logan JI . Milk alkali syndrome . Ulster Med J . 2002;71:132–135
  60. Ranchet G , Gangemi O , Petrone M . Sucralfate in the treatment of gravid pyrosis . G Ital Ostericia Ginecol . 1990;12:1–16
  61. Kallen B . Delivery outcome after the use of acid-suppressing drugs in early pregnancy with special reference to omeprazole . Br J Obstet Gynaecol . 1998;105:877–881
  62. Ruigomez A, Garcia Rodriguez LA, Cattaruzzi C, Troncon MG, Agostinis L, Wallander MA, et al. Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes . Am J Epidemiol . 1999;150:476–481
  63. Larson JD , Patatanian E , Miner PB , Rayburn WF , Robinson MG . Double-blind, placebo-controlled study of ranitidine for gastroesophageal reflux symptoms during pregnancy . Obstet Gynecol . 1997;90:83–87
  64. Magee LA , Inocencion G , Kamboj L , Rosetti F , Koren G . Safety of first trimester exposure to histamine H2 blockers. A prospective cohort study . Dig Dis Sci . 1996;41:1145–1149
  65. Garbis H, Elefant E, Diav-Citrin O, Mastroiacovo P, Schaefer C, Vial T, et al. Pregnancy outcome after exposure to ranitidine and other H2-blockers. A collaborative study of the European Network of Teratology Information Services . Reprod Toxicol . 2005;19:453–458
  66. Morton DM . Pharmacology and toxicology of nizatidine . Scand J Gastroenterol Suppl . 1987;136:1–8
  67. Sankaran K , Yeboah E , Bingham WT , Ninan A . Use of metoclopramide in preterm infants . Dev Pharmacol Ther . 1982;5:114–119
  68. Bailey B, Addis A, Lee A, Sanghvi K, Mastroiacovo P, Mazzone T, et al. Cisapride use during human pregnancy (a prospective, controlled multicenter study) . Dig Dis Sci . 1997;42:1848–1852
  69. Prilosec [package insert] . Wilmington, DE: AstraZeneca; 2001;
  70. Kallen BA . Use of omeprazole during pregnancy—no hazard demonstrated in 955 infants exposed during pregnancy . Eur J Obstet Gynecol Reprod Biol . 2001;96:63–68
  71. Lalkin A, Loebstein R, Addis A, Ramezani-Namin F, Mastroiacovo P, Mazzone T, et al. The safety of omeprazole during pregnancy (a multicenter prospective controlled study) . Am J Obstet Gynecol . 1998;179:727–730
  72. Diav-Citrin O, Arnon J, Shechtman S, Schaefer C, van Tonningen MR, Clementi M, et al. The safety of proton pump inhibitors in pregnancy (a multicentre prospective controlled study) . Aliment Pharmacol Ther . 2005;21:269–275
  73. Wilton LV , Pearce GL , Martin RM , Mackay FJ , Mann RD . The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England . Br J Obstet Gynaecol . 1998;105:882–889
  74. Nielsen GL , Sorensen HT , Thulstrup AM , Tage-Jensen U , Olesen C , Ekbom A . The safety of proton pump inhibitors in pregnancy . Aliment Pharmacol Ther . 1999;13:1085–1089
  75. Jepsen P , Skriver MV , Floyd A , Lipworth L , Schonheyder HC , Sorensen HT . A population-based study of maternal use of amoxicillin and pregnancy outcome in Denmark . Br J Clin Pharmacol . 2003;55:216–221
  76. Witt A, Sommer EM, Cichna M, Postlbauer K, Widhalm A, Gregor H, et al. Placental passage of clarithromycin surpasses other macrolide antibiotics . Am J Obstet Gynecol . 2003;188:816–819
  77. Einarson A, Phillips E, Mawji F, D’Alimonte D, Schick B, Addis A, et al. A prospective controlled multicentre study of clarithromycin in pregnancy . Am J Perinatol . 1998;15:523–525
  78. Drinkard CR , Shatin D , Clouse J . Postmarketing surveillance of medications and pregnancy outcomes (clarithromycin and birth malformations) . Pharmacoepidemiol Drug Saf . 2000;9:549–556
  79. Sedlmayr T , Peters F , Raasch W , Kees F . [Clarithromycin, a new macrolide antibiotic. Effectiveness in puerperal infections and pharmacokinetics in breast milk] . Geburtshilfe Frauenheilkd . 1993;53:488–491
  80. James LF , Lazar VA , Binns W . Effects of sublethal doses of certain minerals on pregnant ewes and fetal development . Am J Vet Res . 1966;27:132–135
  81. Ridgway LP , Karnofsky DA . The effects of metals on the chick embryo (toxicity and production of abnormalities in development) . Ann N Y Acad Sci . 1952;55:203–215
  82. Lione A . Nonprescription drugs as a source of aluminum, bismuth, and iodine during pregnancy . Reprod Toxicol . 1987;1:243–252
  83. Luiten EJ , Hop WC , Lange JF , Bruining HA . Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis . Ann Surg . 1995;222:57–65
  84. Loebstein R, Addis A, Ho E, Andreou R, Sage S, Donnenfeld AE, et al. Pregnancy outcome following gestational exposure to fluoroquinolones (a multicenter prospective controlled study) . Antimicrob Agents Chemother . 1998;42:1336–1339
  85. Larsen H , Nielsen GL , Schonheyder HC , Olesen C , Sorensen HT . Birth outcome following maternal use of fluoroquinolones . Int J Antimicrob Agents . 2001;18:259–262
  86. Moudgal VV , Sobel JD . Antifungal drugs in pregnancy (a review) . Expert Opin Drug Saf . 2003;2:475–483
  87. Dinsmoor MJ . Imipenem-cilastatin . Obstet Gynecol Clin North Am . 1992;19:475–482
  88. Heikkila A , Renkonen OV , Erkkola R . Pharmacokinetics and transplacental passage of imipenem during pregnancy . Antimicrob Agents Chemother . 1992;36:2652–2655
  89. Wunsch MJ , Stanard V , Schnoll SH . Treatment of pain in pregnancy . Clin J Pain . 2003;19:148–155
  90. Fischer G, Johnson RE, Eder H, Jagsch R, Peternell A, Weninger M, et al. Treatment of opioid-dependent pregnant women with buprenorphine . Addiction . 2000;95:239–244
  91. Odegaard I , Stray-Pedersen B , Hallberg K , Haanaes OC , Storrosten OT , Johannesson M . Maternal and fetal morbidity in pregnancies of Norwegian and Swedish women with cystic fibrosis . Acta Obstet Gynecol Scand . 2002;81:698–705
  92. Michel SH , Mueller DH . Impact of lactation on women with cystic fibrosis and their infants (a review of five cases) . J Am Diet Assoc . 1994;94:159–165
  93. Lu EJ , Curet MJ , El-Sayed YY , Kirkwood KS . Medical versus surgical management of biliary tract disease in pregnancy . Am J Surg . 2004;188:755–759
  94. Ramin KD , Ramsey PS . Disease of the gallbladder and pancreas in pregnancy . Obstet Gynecol Clin North Am . 2001;28:571–580
  95. Hempfling W , Dilger K , Beuers U . Systematic review (ursodeoxycholic acid—adverse effects and drug interactions) . Aliment Pharmacol Ther . 2003;18:963–972
  96. Christensen KL , Andersen BN , Vilstrup H . [Primary sclerosing cholangitis with itching treated during pregnancy with ursodeoxycholic acid] . Ugeskr Laeger . 1997;159:7151–7153
  97. Gossard AA , Lindor KD . Pregnancy in a patient with primary sclerosing cholangitis . J Clin Gastroenterol . 2002;35:353–355
  98. Poupon R , Chretien Y , Chazouilleres O , Poupon RE . Pregnancy in women with ursodeoxycholic acid-treated primary biliary cirrhosis . J Hepatol . 2005;42:418–419
  99. Palma J, Reyes H, Ribalta J, Hernandez I, Sandoval L, Almuna R, et al. Ursodeoxycholic acid in the treatment of cholestasis of pregnancy (a randomized, double-blind study controlled with placebo) . J Hepatol . 1997;27:1022–1028
  100. Magriples U . Hepatitis in pregnancy . Semin Perinatol . 1998;22:112–117
  101. Jonas MM , Reddy RK , DeMedina M , Schiff ER . Hepatitis B infection in a large municipal obstetrical population (characterization and prevention of perinatal transmission) . Am J Gastroenterol . 1990;85:277–280
  102. Su GG , Pan KH , Zhao NF , Fang SH , Yang DH , Zhou Y . Efficacy and safety of lamivudine treatment for chronic hepatitis B in pregnancy . World J Gastroenterol . 2004;10:910–912
  103. van Zonneveld M , van Nunen AB , Niesters HG , de Man RA , Schalm SW , Janssen HL . Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection . J Viral Hepat . 2003;10:294–297
  104. Antiretroviral Pregnancy Registry . The Antiretroviral Pregnancy Registry for abacavir, amprenavir, delavirdine, didanosine, efavirenz, indinavir, lamivudine, lamivudine/zidovudine, nelfinavir, nevirapine, ritonavir, saquinavir, saquinavir mesylate, stavudine, zalcitavine, zidovudine, Interim report 1 January 1989 though 31 July 2000 . Antiretroviral Pregnancy Registry . 2000;1–55
  105. Moodley J, Moodley D, Pillay K, Coovadia H, Saba J, van Leeuwen R, et al. Pharmacokinetics and antiretroviral activity of lamivudine alone or when coadministered with zidovudine in human immunodeficiency virus type 1-infected pregnant women and their offspring . J Infect Dis . 1998;178:1327–1333
  106. Chard T . Interferon in pregnancy . J Dev Physiol . 1989;11:271–276
  107. Hiratsuka M , Minakami H , Koshizuka S , Sato I . Administration of interferon-alpha during pregnancy (effects on fetus) . J Perinat Med . 2000;28:372–376
  108. Ozaslan E , Yilmaz R , Simsek H , Tatar G . Interferon therapy for acute hepatitis C during pregnancy . Ann Pharmacother . 2002;36:1715–1718
  109. Rebetol [package insert] . Kenilworth, NJ: Schering; 2004;
  110. Scheinberg IH , Sternlieb I . Pregnancy in penicillamine-treated patients with Wilson’s disease . N Engl J Med . 1975;293:1300–1302
  111. Marecek Z , Graf M . Pregnancy in penicillamine-treated patients with Wilson’s disease . (letter) N Engl J Med . 1976;295:841–842
  112. Sinha S , Taly AB , Prashanth LK , Arunodaya GR , Swamy HS . Successful pregnancies and abortions in symptomatic and asymptomatic Wilson’s disease . J Neurol Sci . 2004;217:37–40
  113. Walshe JM . The management of pregnancy in Wilson’s disease treated with trientine . Q J Med . 1986;58:81–87
  114. Janczewska I , Olsson R , Hultcrantz R , Broome U . Pregnancy in patients with primary sclerosing cholangitis . Liver . 1996;16:326–330
  115. Korkut E , Kisacik B , Akcan Y , Belenli O , Bicik Z , Yucel O . Two successive pregnancies after ursodeoxycholic acid therapy in a previously infertile woman with antimitochondrial antibody-negative primary biliary cirrhosis . Fertil Steril . 2005;83:761–763
  116. Kondrackiene J , Beuers U , Kupcinskas L . Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy . Gastroenterology . 2005;129:894–901
  117. Pruyn SC , Phelan JP , Buchanan GC . Long-term propranolol therapy in pregnancy (maternal and fetal outcome) . Am J Obstet Gynecol . 1979;135:485–489
  118. Fox RE , Marx C , Stark AR . Neonatal effects of maternal nadolol therapy . Am J Obstet Gynecol . 1985;152:1045–1046
  119. Armenti VT , Radomski JS , Moritz MJ , Gaughan WJ , McGrory CH , Coscia LA . Report from the National Transplantation Pregnancy Registry (NTPR) (outcomes of pregnancy after transplantation) . Clin Transpl . 2003;131–141
  120. Bar Oz B , Hackman R , Einarson T , Koren G . Pregnancy outcome after cyclosporine therapy during pregnancy (a meta-analysis) . Transplantation . 2001;71:1051–1055
  121. Nagy S , Bush MC , Berkowitz R , Fishbein TM , Gomez-Lobo V . Pregnancy outcome in liver transplant recipients . Obstet Gynecol . 2003;102:121–128
  122. Jain A, Venkataramanan R, Fung JJ, Gartner JC, Lever J, Balan V, et al. Pregnancy after liver transplantation under tacrolimus . Transplantation . 1997;64:559–565
  123. Kainz A , Harabacz I , Cowlrick IS , Gadgil S , Hagiwara D . Analysis of 100 pregnancy outcomes in women treated systemically with tacrolimus . Transpl Int . 2000;13(Suppl 1):S299–S300
  124. Jain AB, Reyes J, Marcos A, Mazariegos G, Eghtesad B, Fontes PA, et al. Pregnancy after liver transplantation with tacrolimus immunosuppression (a single center’s experience update at 13 years) . Transplantation . 2003;76:827–832
  125. Jankowska I, Oldakowska-Jedynak U, Jabiry-Zieniewicz Z, Cyganek A, Pawlowska J, Teisseyre M, et al. Absence of teratogenicity of sirolimus used during early pregnancy in a liver transplant recipient . Transplant Proc . 2004;36:3232–3233
  126. Le Ray C , Coulomb A , Elefant E , Frydman R , Audibert F . Mycophenolate mofetil in pregnancy after renal transplantation (a case of major fetal malformations) . Obstet Gynecol . 2004;103:1091–1094
  127. Hasler WL . The irritable bowel syndrome during pregnancy . Gastroenterol Clin North Am . 2003;32:385–406 viii
  128. Tytgat GN, Heading RC, Muller-Lissner S, Kamm MA, Scholmerich J, Berstad A, et al. Contemporary understanding and management of reflux and constipation in the general population and pregnancy (a consensus meeting) . Aliment Pharmacol Ther . 2003;18:291–301
  129. Attar A, Lemann M, Ferguson A, Halphen M, Boutron MC, Flourie B, et al. Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation . Gut . 1999;44:226–230
  130. Cameron BD , Phillips MW , Fenerty CA . Milk transfer of rhein in the rhesus monkey . Pharmacology . 1988;36(Suppl 1):221–225
  131. Sicuranza GB , Figueroa R . Uterine rupture associated with castor oil ingestion . J Matern Fetal Neonatal Med . 2003;13:133–134
  132. Einarson A, Mastroiacovo P, Arnon J, Ornoy A, Addis A, Malm H, et al. Prospective, controlled, multicentre study of loperamide in pregnancy . Can J Gastroenterol . 2000;14:185–187
  133. Black RA , Hill DA . Over-the-counter medications in pregnancy . Am Fam Physician . 2003;67:2517–2524
  134. Jenkins JK , Boothby LA . Treatment of itching associated with intrahepatic cholestasis of pregnancy . Ann Pharmacother . 2002;36:1462–1465
  135. Patterson EC , Staszak DJ . Effects of geophagia (kaolin ingestion) on the maternal blood and embryonic development in the pregnant rat . J Nutr . 1977;107:2020–2025
  136. Collins E . Maternal and fetal effects of acetaminophen and salicylates in pregnancy . Obstet Gynecol . 1981;58:57S–62S
  137. Chun-Fai-Chan B, Koren G, Fayez I, Kalra S, Voyer-Lavigne S, Boshier A, et al. Pregnancy outcome of women exposed to bupropion during pregnancy (a prospective comparative study) . Am J Obstet Gynecol . 2005;192:932–936
  138. Einarson TR , Einarson A . Newer antidepressants in pregnancy and rates of major malformations (a meta-analysis of prospective comparative studies) . Pharmacoepidemiol Drug Saf . 2005;14:823–827
  139. GlaxoSmithKline. Study EPIP083. GSK medicine: bupropion and paroxetine. Epidemiology study: preliminary report on bupropion in pregnancy and the occurrence of cardiovascular and major congenital malformation. Available at: http://ctr.gsk.co.uk/summary/paroxetine/epip083.pdf. Accessed October 26, 2005.
  140. Williams M , Wooltorton E . Paroxetine (Paxil) and congenital malformations . CMAJ . 2005;173:1320–1321
  141. Kallen B . Neonate characteristics after maternal use of antidepressants in late pregnancy . Arch Pediatr Adolesc Med . 2004;158:312–316
  142. Kulin NA, Pastuszak A, Sage SR, Schick-Boschetto B, Spivey G, Feldkamp M, et al. Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors (a prospective controlled multicenter study) . JAMA . 1998;279:609–610
  143. Chambers CD , Johnson KA , Dick LM , Felix RJ , Jones KL . Birth outcomes in pregnant women taking fluoxetine . N Engl J Med . 1996;335:1010–1015
  144. Hendrick V , Smith LM , Suri R , Hwang S , Haynes D , Altshuler L . Birth outcomes after prenatal exposure to antidepressant medication . Am J Obstet Gynecol . 2003;188:812–815
  145. Sanz EJ , De-las-Cuevas C , Kiuru A , Bate A , Edwards R . Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome (a database analysis) . Lancet . 2005;365:482–487
  146. Gentile S . The safety of newer antidepressants in pregnancy and breastfeeding . Drug Saf . 2005;28:137–152
  147. McKeigue PM , Lamm SH , Linn S , Kutcher JS . Bendectin and birth defects: I. A meta-analysis of the epidemiologic studies . Teratology . 1994;50:27–37
  148. Guerrant RL, Van Gilder T, Steiner TS, Thielman NM, Slutsker L, Tauxe RV, et al. Practice guidelines for the management of infectious diarrhea . Clin Infect Dis . 2001;32:331–351
  149. Albenza [package insert] . Philadelphia, PA: SmithKline Beecham Pharmaceuticals; 2001;
  150. Gyapong JO , Chinbuah MA , Gyapong M . Inadvertent exposure of pregnant women to ivermectin and albendazole during mass drug administration for lymphatic filariasis . Trop Med Int Health . 2003;8:1093–1101
  151. Torlesse H , Hodges M . Albendazole therapy and reduced decline in haemoglobin concentration during pregnancy (Sierra Leone) . Trans R Soc Trop Med Hyg . 2001;95:195–201
  152. Torlesse H , Hodges M . Anthelminthic treatment and haemoglobin concentrations during pregnancy . Lancet . 2000;356:1083
  153. Niebyl JR . Antibiotics and other anti-infective agents in pregnancy and lactation . Am J Perinatol . 2003;20:405–414
  154. Kacmar J , Cheh E , Montagno A , Peipert JF . A randomized trial of azithromycin versus amoxicillin for the treatment of Chlamydia trachomatis in pregnancy . Infect Dis Obstet Gynecol . 2001;9:197–202
  155. Kigozi GG, Brahmbhatt H, Wabwire-Mangen F, Wawer MJ, Serwadda D, Sewankambo N, et al. Treatment of Trichomonas in pregnancy and adverse outcomes of pregnancy (a subanalysis of a randomized trial in Rakai, Uganda) . Am J Obstet Gynecol . 2003;189:1398–1400
  156. Kline AH , Blattner RJ , Lunin M . Transplacental effect of tetracyclines of teeth . JAMA . 1964;188:178–180
  157. Czeizel AE , Rockenbauer M . Teratogenic study of doxycycline . Obstet Gynecol . 1997;89:524–528
  158. Heinonen OP , Slone D , Shaprio S . Birth defects and drug in pregnancy . Littleton, MA: Publishing Sciences Group; 1977;
  159. Burtin P , Taddio A , Ariburnu O , Einarson TR , Koren G . Safety of metronidazole in pregnancy (a meta-analysis) . Am J Obstet Gynecol . 1995;172:525–529
  160. Caro-Paton T , Carvajal A , Martin de Diego I , Martin-Arias LH , Alvarez Requejo A , Rodriguez Pinilla E . Is metronidazole teratogenic? A meta-analysis . Br J Clin Pharmacol . 1997;44:179–182
  161. Piper JM , Mitchel EF , Ray WA . Prenatal use of metronidazole and birth defects (no association) . Obstet Gynecol . 1993;82:348–352
  162. Sorensen HT, Larsen H, Jensen ES, Thulstrup AM, Schonheyder HC, Nielsen GL, et al. Safety of metronidazole during pregnancy (a cohort study of risk of congenital abnormalities, preterm delivery and low birth weight in 124 women) . J Antimicrob Chemother . 1999;44:854–856
  163. Diav-Citrin O , Shechtman S , Gotteiner T , Arnon J , Ornoy A . Pregnancy outcome after gestational exposure to metronidazole (a prospective controlled cohort study) . Teratology . 2001;63:186–192
  164. Czeizel AE , Rockenbauer M . A population based case-control teratologic study of oral metronidazole treatment during pregnancy . Br J Obstet Gynaecol . 1998;105:322–327
  165. Bertoli D , Borelli G . Fertility study of rifaximin (L/105) in rats . Chemioterapia . 1986;5:204–207
  166. Bertoli D , Borelli G . [Teratogenic action of Rifaximin in the rat and rabbit and its effect on perinatal development in the rat] . Boll Soc Ital Biol Sper . 1984;60:1079–1085
  167. Xifaxan [package insert] . Morrisville, NC: Salix Pharmaceuticals; 2005;
  168. Karhunen M . Placental transfer of metronidazole and tinidazole in early human pregnancy after a single infusion . Br J Clin Pharmacol . 1984;18:254–257
  169. Czeizel AE , Kazy Z , Vargha P . Oral tinidazole treatment during pregnancy and teratogenesis . Int J Gynaecol Obstet . 2003;83:305–306
  170. Evaldson GR , Lindgren S , Nord CE , Rane AT . Tinidazole milk excretion and pharmacokinetics in lactating women . Br J Clin Pharmacol . 1985;19:503–507
  171. Czeizel AE , Rockenbauer M , Sorensen HT , Olsen J . The teratogenic risk of trimethoprim-sulfonamides (a population based case-control study) . Reprod Toxicol . 2001;15:637–646
  172. Vancocin [package insert] . Indianapolis, IN: Eli Lilly; 2000;
  173. Reyes MP , Ostrea EM , Cabinian AE , Schmitt C , Rintelmann W . Vancomycin during pregnancy (does it cause hearing loss or nephrotoxicity in the infant?) . Am J Obstet Gynecol . 1989;161:977–981
  174. Woolfson K , Cohen Z , McLeod RS . Crohn’s disease and pregnancy . Dis Colon Rectum . 1990;33:869–873
  175. Craxi A , Pagliarello F . Possible embryotoxicity of sulfasalazine . Arch Intern Med . 1980;140:1674
  176. Hoo JJ , Hadro TA , Von Behren P . Possible teratogenicity of sulfasalazine . N Engl J Med . 1988;318:1128
  177. Newman NM , Correy JF . Possible teratogenicity of sulphasalazine . Med J Aust . 1983;1:528–529
  178. Mogadam M , Dobbins WO , Korelitz BI , Ahmed SW . Pregnancy in inflammatory bowel disease (effect of sulfasalazine and corticosteroids on fetal outcome) . Gastroenterology . 1981;80:72–76
  179. Norgard B , Czeizel AE , Rockenbauer M , Olsen J , Sorensen HT . Population-based case control study of the safety of sulfasalazine use during pregnancy . Aliment Pharmacol Ther . 2001;15:483–486
  180. Esbjorner E , Jarnerot G , Wranne L . Sulphasalazine and sulphapyridine serum levels in children to mothers treated with sulphasalazine during pregnancy and lactation . Acta Paediatr Scand . 1987;76:137–142
  181. Levi AJ , Fisher AM , Hughes L , Hendry WF . Male infertility due to sulphasalazine . Lancet . 1979;2:276–278
  182. Toovey S , Hudson E , Hendry WF , Levi AJ . Sulphasalazine and male infertility (reversibility and possible mechanism) . Gut . 1981;22:445–451
  183. Chatzinoff M , Guarino JM , Corson SL , Batzer FR , Friedman LS . Sulfasalazine-induced abnormal sperm penetration assay reversed on changing to 5-aminosalicylic acid enemas . Dig Dis Sci . 1988;33:108–110
  184. Kjaergaard N , Christensen LA , Lauritsen JG , Rasmussen SN , Hansen SH . Effects of mesalazine substitution on salicylazosulfapyridine-induced seminal abnormalities in men with ulcerative colitis . Scand J Gastroenterol . 1989;24:891–896
  185. Moody GA , Probert C , Jayanthi V , Mayberry JF . The effects of chronic ill health and treatment with sulphasalazine on fertility amongst men and women with inflammatory bowel disease in Leicestershire . Int J Colorectal Dis . 1997;12:220–224
  186. Habal FM , Hui G , Greenberg GR . Oral 5-aminosalicylic acid for inflammatory bowel disease in pregnancy (safety and clinical course) . Gastroenterology . 1993;105:1057–1060
  187. Marteau P , Tennenbaum R , Elefant E , Lemann M , Cosnes J . Foetal outcome in women with inflammatory bowel disease treated during pregnancy with oral mesalazine microgranules . Aliment Pharmacol Ther . 1998;12:1101–1108
  188. Trallori G, d’Albasio G, Bardazzi G, Bonanomi AG, Amorosi A, Del Carlo P, et al. 5-Aminosalicylic acid in pregnancy (clinical report) . Ital J Gastroenterol . 1994;26:75–78
  189. Diav-Citrin O, Park YH, Veerasuntharam G, Polachek H, Bologa M, Pastuszak A, et al. The safety of mesalamine in human pregnancy (a prospective controlled cohort study) . Gastroenterology . 1998;114:23–28
  190. Norgard B , Fonager K , Pedersen L , Jacobsen BA , Sorensen HT . Birth outcome in women exposed to 5-aminosalicylic acid during pregnancy (a Danish cohort study) . Gut . 2003;52:243–247
  191. Nelis GF . Diarrhoea due to 5-aminosalicylic acid in breast milk . Lancet . 1989;1:383
  192. Czeizel AE , Rockenbauer M , Sorensen HT , Olsen J . Augmentin treatment during pregnancy and the prevalence of congenital abnormalities (a population-based case-control teratologic study) . Eur J Obstet Gynecol Reprod Biol . 2001;97:188–192
  193. Berkovitch M, Diav-Citrin O, Greenberg R, Cohen M, Bulkowstein M, Shechtman S, et al. First-trimester exposure to amoxycillin/clavulanic acid (a prospective, controlled study) . Br J Clin Pharmacol . 2004;58:298–302
  194. Rodriguez-Pinilla E , Martinez-Frias ML . Corticosteroids during pregnancy and oral clefts (a case-control study) . Teratology . 1998;58:2–5
  195. Carmichael SL , Shaw GM . Maternal corticosteroid use and risk of selected congenital anomalies . Am J Med Genet . 1999;86:242–244
  196. Park-Wyllie L, Mazzotta P, Pastuszak A, Moretti ME, Beique L, Hunnisett L, et al. Birth defects after maternal exposure to corticosteroids (prospective cohort study and meta-analysis of epidemiological studies) . Teratology . 2000;62:385–392
  197. Gur C , Diav-Citrin O , Shechtman S , Arnon J , Ornoy A . Pregnancy outcome after first trimester exposure to corticosteroids (a prospective controlled study) . Reprod Toxicol . 2004;18:93–101
  198. Armenti VT , Moritz MJ , Cardonick EH , Davison JM . Immunosuppression in pregnancy (choices for infant and maternal health) . Drugs . 2002;62:2361–2375
  199. Gluck PA , Gluck JC . A review of pregnancy outcomes after exposure to orally inhaled or intranasal budesonide . Curr Med Res Opin . 2005;21:1075–1084
  200. Norjavaara E , de Verdier MG . Normal pregnancy outcomes in a population-based study including 2,968 pregnant women exposed to budesonide . J Allergy Clin Immunol . 2003;111:736–742
  201. Patlas N , Golomb G , Yaffe P , Pinto T , Breuer E , Ornoy A . Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats . Teratology . 1999;60:68–73
  202. Del Campo M , Kosaki K , Bennett FC , Jones KL . Developmental delay in fetal aminopterin/methotrexate syndrome . Teratology . 1999;60:10–12
  203. French AE , Koren G . Effect of methotrexate on male fertility . Can Fam Physician . 2003;49:577–578
  204. Polifka JE , Friedman JM . Teratogen update (azathioprine and 6-mercaptopurine) . Teratology . 2002;65:240–261
  205. Saarikoski S , Seppala M . Immunosuppression during pregnancy (transmission of azathioprine and its metabolites from the mother to the fetus) . Am J Obstet Gynecol . 1973;115:1100–1106
  206. Norgard B , Pedersen L , Fonager K , Rasmussen SN , Sorensen HT . Azathioprine, mercaptopurine and birth outcome (a population-based cohort study) . Aliment Pharmacol Ther . 2003;17:827–834
  207. Alstead EM , Ritchie JK , Lennard-Jones JE , Farthing MJ , Clark ML . Safety of azathioprine in pregnancy in inflammatory bowel disease . Gastroenterology . 1990;99:443–446
  208. Francella A , Dyan A , Bodian C , Rubin P , Chapman M , Present DH . The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease (a retrospective cohort study) . Gastroenterology . 2003;124:9–17
  209. Khan ZH , Mayberry JF , Spiers N , Wicks AC . Retrospective case series analysis of patients with inflammatory bowel disease on azathioprine. A district general hospital experience . Digestion . 2000;62:249–254
  210. Moskovitz DN, Bodian C, Chapman ML, Marion JF, Rubin PH, Scherl E, et al. The effect on the fetus of medications used to treat pregnant inflammatory bowel-disease patients . Am J Gastroenterol . 2004;99:656–661
  211. Bertschinger P , Himmelmann A , Risti B , Follath F . Cyclosporine treatment of severe ulcerative colitis during pregnancy . Am J Gastroenterol . 1995;90:330
  212. Anderson JB , Turner GM , Williamson RC . Fulminant ulcerative colitis in late pregnancy and the puerperium . J R Soc Med . 1987;80:492–494
  213. Baumgart DC , Sturm A , Wiedenmann B , Dignass AU . Uneventful pregnancy and neonatal outcome with tacrolimus in refractory ulcerative colitis . Gut . 2005;54:1822–1823
  214. Ehrenpreis ED , Kane SV , Cohen LB , Cohen RD , Hanauer SB . Thalidomide therapy for patients with refractory Crohn’s disease (an open-label trial) . Gastroenterology . 1999;117:1271–1277
  215. Thalomid [package insert] . Summit, NJ: Celgene Corp; 2000;
  216. Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, et al. Maintenance infliximab for Crohn’s disease (the ACCENT I randomised trial) . Lancet . 2002;359:1541–1549
  217. Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, et al. Infliximab for induction and maintenance therapy for ulcerative colitis . N Engl J Med . 2005;353:2462–2476
  218. Srinivasan R . Infliximab treatment and pregnancy outcome in active Crohn’s disease . Am J Gastroenterol . 2001;96:2274–2275
  219. James RL , Pearson LL . Successful treatment of pregnancy-triggered Crohn’s disease complicated by severe recurrent life-threatening gastrointestinal bleeding (abstr) . Am J Gastroenterol . 2001;96:S295
  220. Bank L , Hunt B . Unexpected dramatic clinical response of psoriasis lesions and unexpected pregnancy in an infertile patient in response to treatment with anti-tumor necrosis factor monoclonal antibody for Crohn’s disease (abstr) . Am J Gastroenterol . 2002;97:S260
  221. Burt MJ , Frizelle FA , Barbezat GO . Pregnancy and exposure to infliximab (anti-tumor necrosis factor-alpha monoclonal antibody) . J Gastroenterol Hepatol . 2003;18:465–466
  222. Lichtenstein G , Cohen RD , Feagan BG , et al.   Safety of infliximab in Crohn’s disease (data from the 5000-patient TREAT Registry) . (abstr) Gastroenterology . 2004;126:A54
  223. Katz JA , Antoni C , Keenan GF , Smith DE , Jacobs SJ , Lichtenstein GR . Outcome of pregnancy in women receiving infliximab for the treatment of Crohn’s disease and rheumatoid arthritis . Am J Gastroenterol . 2004;99:2385–2392
  224. Mahadevan U, Kane S, Sandborn WJ, Cohen RD, Hanson K, Terdiman JP, et al. Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn’s disease . Aliment Pharmacol Ther . 2005;21:733–738
  225. Vasiliauskas E , Barry M , Dubinsky M , et al.   High serum levels of infliximab detected in the newborn of a mother receiving infliximab during pregnancy . (abstr) Gastroenterology . 2005;128:P33
  226. Peltier M , James D , Ford J , et al.   Infliximab levels in breast-milk of a nursing Crohn’s patient . (abstr) Am J Gastroenterol . 2001;96:P258
  227. Hanauer SB , Lukas M , MacIntosh D , et al.   A randomized, double-blind, placebo controlled trial of the human anti-TNF alpha monoclonal antibody adalimumab for the induction of remission in patients with moderate to severely active Crohn’s disease . (abstr) Gastroenterology . 2004;127:332
  228. Vesga L , Terdiman JP , Mahadevan U . Adalimumab use in pregnancy . Gut . 2005;54:890
  229. Olsen SF, Sorensen JD, Secher NJ, Hedegaard M, Henriksen TB, Hansen HS, et al. Randomised controlled trial of effect of fish-oil supplementation on pregnancy duration . Lancet . 1992;339:1003–1007
  230. Rossi E , Costa M . Fish oil derivatives as a prophylaxis of recurrent miscarriage associated with antiphospholipid antibodies (APL) (a pilot study) . Lupus . 1993;2:319–323
  231. Food and Drug Administration . Regulations . 1980;44:37434–37467

PII: S0016-5085(06)00865-1

doi: 10.1053/j.gastro.2006.04.049

Gastroenterology
Volume 131, Issue 1 , Pages 283-311 , July 2006

Article Tools